133 related articles for article (PubMed ID: 38226846)
21. Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population-based study from 1993 to 2017.
van Doeveren T; van der Mark M; van Leeuwen PJ; Boormans JL; Aben KKH
BJU Int; 2021 Sep; 128(3):343-351. PubMed ID: 33690922
[TBL] [Abstract][Full Text] [Related]
22. Preoperative upper tract invasive diagnostic modalities are associated with intravesical recurrence following surgery for upper tract urothelial carcinoma: A population-based study.
Liedberg F; Hagberg O; Häggström C; Aljabery F; Gårdmark T; Hosseini A; Jahnson S; Jerlström T; Ströck V; Söderkvist K; Ullén A; Holmberg L; Bobjer J
PLoS One; 2023; 18(2):e0281304. PubMed ID: 36730353
[TBL] [Abstract][Full Text] [Related]
23. Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
Shiga M; Nagumo Y; Chihara I; Nitta S; Kojo K; Kimura T; Kandori S; Kojima T; Okuyama A; Higashi T; Nishiyama H
Int J Urol; 2021 Aug; 28(8):814-819. PubMed ID: 34013614
[TBL] [Abstract][Full Text] [Related]
24. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population.
Fang D; Xiong G; Li X; Kang Y; Zhang L; Zhao G; Chen X; Yao L; Zhang X; Yu W; Gong K; Song Y; He Q; He Z; Zhou L; Guo Y
Urol Oncol; 2015 Feb; 33(2):66.e1-11. PubMed ID: 25240760
[TBL] [Abstract][Full Text] [Related]
25. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
Xylinas E; Kluth L; Passoni N; Trinh QD; Rieken M; Lee RK; Fajkovic H; Novara G; Margulis V; Raman JD; Lotan Y; Rouprêt M; Aziz A; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Walton T; Karakiewicz PI; Montorsi F; Zerbib M; Scherr DS; Shariat SF;
Eur Urol; 2014 Mar; 65(3):650-8. PubMed ID: 24070577
[TBL] [Abstract][Full Text] [Related]
26. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
[TBL] [Abstract][Full Text] [Related]
27. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
Kates M; Badalato GM; Gupta M; McKiernan JM
BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
[TBL] [Abstract][Full Text] [Related]
28. Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study.
Marcq G; Foerster B; Abufaraj M; Matin SF; Azizi M; Gupta M; Li WM; Seisen T; Clinton T; Xylinas E; Mir MC; Schweitzer D; Mari A; Kimura S; Bandini M; Mathieu R; Ku JH; Guruli G; Grabbert M; Czech AK; Muilwijk T; Pycha A; D'Andrea D; Petros FG; Spiess PE; Bivalacqua T; Wu WJ; Rouprêt M; Krabbe LM; Hendricksen K; Egawa S; Briganti A; Moschini M; Graffeille V; Autorino R; John P; Heidenreich A; Chlosta P; Joniau S; Soria F; Pierorazio PM; Shariat SF; Kassouf W
Eur Urol Focus; 2022 Mar; 8(2):491-497. PubMed ID: 33773965
[TBL] [Abstract][Full Text] [Related]
29. Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience.
Campi R; Cotte J; Sessa F; Seisen T; Tellini R; Amparore D; Mormile N; Gobert A; Mari A; Porpiglia F; Serni S; Minervini A; Rouprêt M
World J Urol; 2019 Nov; 37(11):2303-2311. PubMed ID: 31062121
[TBL] [Abstract][Full Text] [Related]
30. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy.
Miest T; Khanna A; Sharma V; Hensley PJ; Campbell R; Thapa P; Zganjar A; Tollefson MK; Thompson RH; Frank I; Karnes RJ; Potretzke A; Matin SF; Murthy PB; Haber GP; Lee B; Boorjian SA
J Urol; 2022 Feb; 207(2):284-292. PubMed ID: 34547921
[TBL] [Abstract][Full Text] [Related]
32. Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Ryoo H; Kim J; Kim T; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
Cancer Res Treat; 2021 Jul; 53(3):795-802. PubMed ID: 33421984
[TBL] [Abstract][Full Text] [Related]
33. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.
Mandalapu RS; Remzi M; de Reijke TM; Margulis V; Palou J; Kapoor A; Yossepowitch O; Coleman J; Traxer O; Anderson JK; Catto J; de la Rosette J; O'Brien T; Zlotta A; Matin SF
World J Urol; 2017 Mar; 35(3):355-365. PubMed ID: 27233780
[TBL] [Abstract][Full Text] [Related]
34. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.
Ouzzane A; Colin P; Ghoneim TP; Zerbib M; De La Taille A; Audenet F; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M
World J Urol; 2013 Feb; 31(1):189-97. PubMed ID: 23229227
[TBL] [Abstract][Full Text] [Related]
35. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
[TBL] [Abstract][Full Text] [Related]
36. Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence.
Huang EY; Tai MC; Chung HJ; Chang YH; Huang WJ
Int Braz J Urol; 2023; 49(4):469-478. PubMed ID: 37267612
[TBL] [Abstract][Full Text] [Related]
37. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.
Rouprêt M; Seisen T; Birtle AJ; Capoun O; Compérat EM; Dominguez-Escrig JL; Gürses Andersson I; Liedberg F; Mariappan P; Hugh Mostafid A; Pradere B; van Rhijn BWG; Shariat SF; Rai BP; Soria F; Soukup V; Wood RG; Xylinas EN; Masson-Lecomte A; Gontero P
Eur Urol; 2023 Jul; 84(1):49-64. PubMed ID: 36967359
[TBL] [Abstract][Full Text] [Related]
38. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
39. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
[TBL] [Abstract][Full Text] [Related]
40. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
Thalmann GN; Markwalder R; Walter B; Studer UE
J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
